Meloxicam Basi

Meloxicam, the active ingredient in Meloxicam Basi, is a nonsteroidal anti-inflammatory drug (NSAID) presented as an oral tablet for oral use. It treats inflammatory joint conditions such as rheumatoid arthritis, osteoarthritis and ankylosing spondylitis, and can be prescribed for acute pain.

GNH USA supplies Meloxicam Basi as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Meloxicam is used to manage inflammatory and painful musculoskeletal disorders by inhibiting prostaglandin synthesis.

- Rheumatoid arthritis: reduces joint inflammation and pain, improving functional ability. - Osteoarthritis: alleviates chronic joint discomfort and stiffness. - Ankylosing spondylitis: lessens spinal inflammation and associated pain. - Acute pain: provides short‑term relief for moderate to severe pain episodes.

Meloxicam may cause a range of adverse reactions, from mild to serious.

Common Side Effects: - Gastrointestinal discomfort such as dyspepsia or nausea. - Headache or dizziness. - Mild skin rash or pruritus. - Edema, particularly in the lower extremities.

Serious or Rare Side Effects: - Peptic ulcer disease or gastrointestinal bleeding. - Elevated liver enzymes or hepatic injury. - Renal impairment or sudden loss of kidney function. - Severe hypersensitivity reactions, including Stevens‑Johnson syndrome. - Cardiovascular events such as myocardial infarction or stroke.

Before prescribing Meloxicam, clinicians should consider patient‑specific risk factors and monitor appropriately. - Cardiovascular risk: avoid in patients with recent myocardial infarction or uncontrolled hypertension. - Gastrointestinal risk: use cautiously in those with a history of ulcers or bleeding. - Renal function: assess baseline kidney function and adjust if impairment is present. - Hepatic health: monitor liver enzymes in patients with liver disease. - Pregnancy and lactation: avoid unless benefits outweigh potential risks. - Store at ambient temperature: keep below 25 °C, retain in original packaging, protect from moisture and direct sunlight.

Meloxicam can interact with several drug classes, requiring careful review of a patient’s medication list.

Major Interactions (Avoid): - Anticoagulants (e.g., warfarin): increased risk of serious bleeding. - Other NSAIDs or COX‑2 inhibitors: heightened gastrointestinal and renal toxicity.

Moderate Interactions (Monitor Closely): - ACE inhibitors or ARBs: may reduce renal perfusion, especially in volume‑depleted patients. - Diuretics: potential for decreased renal function and electrolyte disturbances. - Lithium: NSAIDs can raise lithium levels, risking toxicity.